Drug Shortage Report for ALTACE
Report ID | 56810 |
Drug Identification Number | 02221829 |
Brand name | ALTACE |
Common or Proper name | ALTACE |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | RAMIPRIL |
Strength(s) | 1.25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 30 caps |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-08-08 |
Estimated end date | |
Actual end date | 2018-08-29 |
Shortage status | Resolved |
Updated date | 2018-08-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2018-08-31 | French | Compare |
v10 | 2018-08-31 | English | Compare |
v9 | 2018-08-24 | French | Compare |
v8 | 2018-08-24 | English | Compare |
v7 | 2018-08-10 | French | Compare |
v6 | 2018-08-10 | English | Compare |
v5 | 2018-08-03 | French | Compare |
v4 | 2018-08-03 | English | Compare |
v3 | 2018-08-02 | English | Compare |
v2 | 2018-07-27 | French | Compare |
v1 | 2018-07-27 | English | Compare |
Showing 1 to 11 of 11